BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,139,808 | -75.4% | 114,600 | -75.9% | 0.00% | -78.6% |
| Q2 2023 | $41,146,996 | +627.1% | 474,700 | +715.6% | 0.01% | +600.0% |
| Q1 2023 | $5,659,368 | -60.8% | 58,200 | -58.2% | 0.00% | -71.4% |
| Q4 2022 | $14,426,506 | +40.5% | 139,400 | +15.1% | 0.01% | +75.0% |
| Q3 2022 | $10,266,000 | -18.6% | 121,100 | -20.4% | 0.00% | -20.0% |
| Q2 2022 | $12,613,000 | – | 152,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 194,500 | $16,488,000 | 0.03% |
| SIMPLEX TRADING, LLC | 65,000 | $5,510,000 | 0.01% |
| JANE STREET GROUP, LLC | 121,100 | $10,266,000 | 0.00% |
| Worth Venture Partners, LLC | 14,200 | $5,000 | 0.00% |
| IMC-Chicago, LLC | 18,000 | $1,526,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |